Renovaro Biosciences 10K 2018 Annual report | RENB Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: absorption, academia, accessed, Adaptimmune, adenosine, advent, affinity, Ambassador, amelioration, analytical, andWeird, Ankara, Ann, antiretroviral, ASU, Atara, Atlanta, attenuated, Baltimore, binding, biology, Bionor, biopharma, biosafety, Biosantech, BLA, bluebird, Blvd, bone, boost, bound, Brazil, breaking, briefly, broadened, broader, broadly, CA, California, capacity, capture, carcinogenicity, Carl, CDC, chemistry, children, chimeric, choice, clade, clarification, Clarifying, Clinton, CMC, comprised, comprising, condensed, content, convening, cumbersome, curative, customary, David, de, deaminase, dedicated, depleted, destroying, deterioration, disappointing, disciplined, dispensing, dispersed, distinct, distinction, dividing, donated, dosage, dosing, dual, Dybul, East, editing, effort, electronically, electroporation, elusive, enochian, envelope, Ester, Evelyn, Evry, excretion, expenditure, expert, fall, fatal, FDCA, Feb, fewer, fidelity, fight, Finland, Finzi, footprint, forgiven, forma, forward, fourth, fundraising, GA, GammaDelta, gene, geographically, Geovax, Gibb, GlaxoSmithKline, GlobalData, Globecan, Graft, groundbreaking, GTU, Gumrukcu, Hardy, hematologic, hematological, hematopoietic, heterogeneity, hidden, HSC, humoral, IBC, ideal, immunodeficiency, inactivate, inactivated, incomplete, infected, infection, InnaVirVax, input, INSERM, intensify, intercompany, intramuscularly, intranasal, Iovance, IRB, issuable, Juno, jurisdiction, Kiem, Kite, Land, lentiviral, lessee, leukemia, licensee, licensor, licensure, lipase, lipoprotein, Liu, logistic, lowest, marrow, maximize, Med, memory, merged, metabolism, mice, mimic, mimicking, modulate, molecular, multi, multitude, mutation, mutually, necessity, NIH, NK, NKT, nominate, Nominating, nomination, nondisclosure, nonexclusive, Notehad, notify, OBA, ofWeird, Olympic, oncolytic, opportunistic, Oslo, OTC, outweigh, Oyi, panel, paradoxically, paramount, Particle, passenger, Pasteur, PCAOB, PDUFA, peptide, perpetual, persist, PharmaPoint, pHLA, PHSA, physician, placebo, plasmid, plasticity, Plaza, Postapproval, potent, precisely, preferential, preliminarily, prescribing, preserve, primate, pro, proceed, proliferation, promptly, proxy, purity, qualitative, RAC, radically, rata, rationale, reactive, Realty, receptor, recommence, reconsider, Regenxbio, rentable, repair, replicate, replication, repopulate, reproductive, reservoir, resistant, rest, restorative, resubmission, resubmitted, RodaHusman, Rodeo, roll, rVSV, Sadler, Sandler, Sangamo, Sapirstein, satisfaction, Scienceentered, seller, shelf, Shire, silence, silent, Similarly, simply, simultaneously, slowly, Spain, spawned, standalone, Standstill, sterilizing, Steven, Stockat, stomach, sublessee, sublessor, sublicensable, submission, substantive, succumb, surveillance, susceptible, suspected, syngeneic, synthetic, Tampere, Tat, TCR, team, tenant, theaugust, theconsideration, thefair, thefinancial, theMarch, theory, Ther, TheraVax, thereunder, toEnochian, transmission, trend, UK, unaffiliated, unannounced, undetectable, uniQure, vesicular, viable, voluntarily, waiver, wasoriginallyconvertible, Weird, welfare, wellcontrolled, whichever, Wong

Removed: adjuvant, advice, affiliated, age, Alberto, analyze, APT, arm, attached, attendance, attention, attract, autoimmune, awarded, background, bank, belong, beneficially, billed, BioFund, branding, breach, Canadian, car, care, Cellin, certainty, certificate, CFO, cheaper, chemical, Christensen, club, collateral, commenced, compensate, complexity, computer, computing, conclusion, confirmation, constitute, contemplated, cooperation, Copenhagen, costly, court, DC, defray, Degn, demonstrated, Dendreon, deter, differential, difficulty, disposition, distributed, DKTI, Dutch, duty, earned, efficiency, efficient, employing, encounter, ending, enforced, enrolling, estate, evidenced, evident, exceed, exhibit, expedient, expressed, favorable, Finnish, Fondazione, formal, formation, found, fritstillet, function, functionally, Genoa, giscad, granting, Grenoble, handful, Harvard, head, hire, holding, home, hospital, inability, inadequate, indirect, Industri, infringement, injection, insolvency, insufficient, interfere, interpretation, inventive, investment, IPRP, IST, jaro, judgment, Kellogg, Krone, la, lawful, legislation, lesser, line, Lone, mage, managing, manner, Martino, mature, MBA, medicine, Medwell, merger, microRNA, ml, mobile, Northwestern, Novicol, NY, omission, online, oral, outcome, overexpressed, owner, Paringenix, Patentability, Patterson, pension, percent, percentage, pharmaco, phenotype, phone, picture, planning, pleasure, PNU, power, preliminary, presence, president, principal, promote, prostate, reading, recipient, recommend, recruitment, reimburse, reimbursement, relationship, released, repaid, representation, requisite, resignation, restriction, retain, route, royalty, safer, salary, San, School, secrecy, secreted, securing, security, segregation, senior, serve, shared, shortly, Sobrero, solution, stop, straight, subparagraph, subscription, surface, surgical, Symbion, timely, tolerogenic, trademarking, Treaty, turnkey, understandable, University, unpredictable, usage, utilization, valuable, vehicle, venture, vigilance, volatility, worked, writing, wrongdoing, York

(1)	The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and

(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

Date: October 1, 2018

/s/ Robert Wolfe
Robert Wolfe
Chief Financial Officer (Principal Financial Officer)

Renovaro Biosciences (RENB) 10-K2018 FY Annual report

Content analysis